Literature DB >> 23774690

Distribution of the Val108/158Met polymorphism of the COMT gene in healthy Mexican population.

Thelma Beatriz González-Castro1, Carlos Tovilla-Zárate, Isela Juárez-Rojop, Sherezada Pool García, Alma Genis, Humberto Nicolini, Lilia López Narváez.   

Abstract

Catechol-O-methyltransferase (COMT) inactivates the catecholamines adrenaline, noradrenaline and dopamine. On the other hand, some studies have reported that the enzymatic activity of COMT is partly genetically determined. With regard to the COMT gene, the most studied polymorphism is the functional variant Val108/158Met (rs4680), which results in substantial three- to four-fold variations in enzyme activity. To date, the rs4680 polymorphism of COMT has been associated with a number of disorders. In addition, this polymorphism has been found to have important differences in frequency according to the studied population. Therefore, the aim of the present study was to evaluate the frequency of a common single nucleotide polymorphism (SNP) Val108/158Met of the COMT gene in the Mexican population. Accordingly, we recruited 431 healthy volunteers. Our sample consisted of 111 healthy individuals from Mexico City and 320 individuals from the state of Tabasco, Mexico. We observed that Met was the most common allele, ranging from 57% (Tabasco) to 85% (Mexico City). In addition, we analyzed the frequency of Val108/158Met polymorphism of Caucasian (54% Met allele), Asian (29% Met allele) and African (34% Met allele) populations separately and also in comparison with Mexican (63% Met allele) population. In conclusion, the distribution of the Val108/158Met polymorphism distinguishes the Mexican population studied from other populations, but it is necessary to increase the size of the sample to get more conclusive results.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COMT; COMT gene; Distribution; Mexican population; PFC; SNP; Val108/158Met; catechol-O-methyltransferase; prefrontal cortex; single nucleotide polymorphism

Mesh:

Substances:

Year:  2013        PMID: 23774690     DOI: 10.1016/j.gene.2013.05.068

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.

Authors:  Mariana Cherner; Caitlin W-M Watson; Rowan Saloner; Laura E Halpin; Arpi Minassian; Sarah S Murray; Florin Vaida; Chad Bousman; Ian Everall
Journal:  Addict Behav       Date:  2019-06-12       Impact factor: 4.591

2.  Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy.

Authors:  Jennie Xu; Anya Umlauf; Scott Letendre; Donald Franklin; William S Bush; Joseph H Atkinson; John Keltner; Ronald J Ellis
Journal:  AIDS       Date:  2019-08-01       Impact factor: 4.632

3.  Study on genes of the serotonergic system and suicidal behavior: protocol for a case-control study in Mexican population.

Authors:  Carlos Alfonso Tovilla-Zárate; Thelma Beatriz González-Castro; Isela Juárez-Rojop; Sherezada Pool García; Martha Patricia Velázquez-Sánchez; Mario Villar-Soto; Alma Genis; Humberto Nicolini; María Lilia López-Narváez; María Antonia Jiménez-Santos
Journal:  BMC Psychiatry       Date:  2014-02-05       Impact factor: 3.630

4.  Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors.

Authors:  Savita G Bhakta; Gregory A Light; Jo A Talledo; Bryan Balvaneda; Erica Hughes; Alexis Alvarez; Brinda K Rana; Jared W Young; Neal R Swerdlow
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.678

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.